Vik Chopra

Stock Analyst at Wells Fargo

(2.24)
# 1,486
Out of 4,667 analysts
25
Total ratings
50%
Success rate
-0.93%
Average return

Stocks Rated by Vik Chopra

NeuroPace
Nov 13, 2024
Maintains: Overweight
Price Target: $15$13
Current: $9.19
Upside: +41.46%
Globus Medical
Nov 6, 2024
Maintains: Overweight
Price Target: $78$88
Current: $83.59
Upside: +5.28%
Masimo
Nov 6, 2024
Maintains: Overweight
Price Target: $160$171
Current: $164.95
Upside: +3.67%
Envista Holdings
Oct 8, 2024
Initiates: Equal-Weight
Price Target: $20
Current: $20.37
Upside: -1.82%
Solventum
Aug 9, 2024
Maintains: Equal-Weight
Price Target: $69$64
Current: $68.39
Upside: -6.42%
CONMED
Aug 1, 2024
Maintains: Equal-Weight
Price Target: $77$71
Current: $70.69
Upside: +0.44%
Alphatec Holdings
Aug 1, 2024
Maintains: Overweight
Price Target: $26$19
Current: $9.93
Upside: +91.34%
Integra LifeSciences Holdings
May 7, 2024
Downgrades: Equal-Weight
Price Target: $45$25
Current: $22.93
Upside: +9.03%
Enovis
Feb 23, 2024
Maintains: Overweight
Price Target: $73$79
Current: $44.78
Upside: +76.42%